Bicycle Therapeutics (BCYC) Other Accumulated Expenses (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Other Accumulated Expenses data on file, last reported at $483000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 56.31% year-over-year to $483000.0; the trailing twelve-month figure through Mar 2026 stood at $483000.0 (up 56.31% YoY), and the FY2025 full-year result was $136000.0, down 54.21% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $483000.0, up from $136000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.5 million in Q4 2022 and bottomed at $136000.0 in Q4 2025.
• The 5-year median for Other Accumulated Expenses is $384000.0 (2022), against an average of $504529.4.
• The widest annual swing landed in 2022, when Other Accumulated Expenses soared 1396.88%; it then plunged 82.54% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $1.5 million in 2022, then sank by 82.54% to $257000.0 in 2023, then gained by 15.56% to $297000.0 in 2024, then plunged by 54.21% to $136000.0 in 2025, then soared by 255.15% to $483000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $483000.0 (Q1 2026), $136000.0 (Q4 2025), and $204000.0 (Q3 2025), per Business Quant data.

Peer Comparison